ERBB2 and breast carcinoma: We did not find any obvious association between molecular subtypes of the available breast cancer cell lines in our dataset, including their HER2 status [51–53], that could explain the inverse relationship between the length of the T(C>D)D motif clusters and bicalutamide sensitivity presented in Fig. 4b.